The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study
Abstract
It has not been firmly established whether disturbed calcium-phosphate metabolism affects progression of chronic kidney disease (CKD) in humans. In this cohort study of 227 nondiabetic patients with CKD, we assessed fibroblast growth factor 23 (FGF23) plasma concentrations in addition to other variables involved in calcium-phosphate metabolism, and we followed 177 of the patients prospectively for a median of 53 months to assess progression of renal disease. In the baseline cohort, we found a significant inverse correlation between glomerular filtration rate and both c-terminal and intact FGF23 levels (both P < 0.001). The 65 patients who experienced a doubling of serum creatinine and/or terminal renal failure were significantly older, had a significantly lower glomerular filtration rate at baseline, and significantly higher levels of intact parathormone, c-terminal and intact FGF23, and serum phosphate (all P < 0.001). Cox regression analysis revealed that both c-terminal and intact FGF23 independently predict progression of CKD after adjustment for age, gender, GFR, proteinuria, and serum levels of calcium, phosphate, and parathyroid hormone. The mean follow-up time to a progression end point was 46.9 (95% CI 40.2 to 53.6) months versus 72.5 (95% CI 67.7 to 77.3) months for patients with c-terminal FGF23 levels above or below the optimal cut-off level of 104 rU/mL (derived by receiver operator curve analysis), respectively. In conclusion, FGF23 is a novel independent predictor of progression of renal disease in patients with nondiabetic CKD. Its pathophysiological significance remains to be elucidated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,596
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101545198 · Cited by 1,457
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
GANESH, S. K., STACK, A. G., LEVIN, N. W., HULBERT-SHEARON, T., & PORT, F. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102131 · Cited by 1,204
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
Jonsson, K. B., Zahradnik, R., Larsson, T., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 914
Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease
Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z., & Curhan, G. (2005) · Circulation · doi:10.1161/circulationaha.105.553198 · Cited by 885
Larsson, T., Nisbeth, U. L. F., Ljunggren, Ö., Jüppner, H., & Jonsson, K. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00328.x · Cited by 689
Ferrari, S. L., Bonjour, J.-P., & Rizzoli, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1039 · Cited by 518
Shimada, T., Urakawa, I., Yamazaki, Y., Hasegawa, H., Hino, R., Yoneya, T., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.102 · Cited by 429
Bostom, A. G., Kronenberg, F., & Ritz, E. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000022011.35035.f3 · Cited by 410
Self-citationSerum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis
Weber, T. J., Liu, S., Indridason, O. S., & Quarles, L. D. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1227 · Cited by 354
Shigematsu, T., Kazama, J. J., Yamashita, T., Fukumoto, S., Hosoya, T., Gejyo, F., & Fukagawa, M. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.04.029 · Cited by 326
Arterial calcification and pathology in uremic patients undergoing dialysis
Ibels, L. S., Alfrey, A. C., Huffer, W. E., Craswell, P. W., Anderson, J. T., & Weil, R. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)91118-5 · Cited by 297
Regulation of Vascular Calcification: Roles of Phosphate and Osteopontin
Giachelli, C. M., Speer, M. Y., Li, X., Rajachar, R. M., & Yang, H. (2005) · Circulation Research · doi:10.1161/01.res.0000161997.24797.c0 · Cited by 291
FGF-23 in patients with end-stage renal disease on hemodialysis
Imanishi, Y., Inaba, M., Nakatsuka, K., Nagasue, K., Okuno, S., Yoshihara, A., Miura, M., Miyauchi, A., Kobayashi, K., Miki, T., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00604.x · Cited by 272
Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats
Schwarz, U., Amann, K., Orth, S. R., Simonaviciene, A., Wessels, S., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00951.x · Cited by 249
Self-citation“Phosphatonins” and the regulation of phosphorus homeostasis
Berndt, T. J., Schiavi, S., & Kumar, R. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00072.2005 · Cited by 230
Renal toxicity of phosphate in rats
Haut, L. L., Alfrey, A. C., Guggenheim, S., Buddington, B., & Schrier, N. (1980) · Kidney International · doi:10.1038/ki.1980.85 · Cited by 201
Christiansen, C., Rødbro, P., Christensen, M., Hartnack, B., & Transbøl, I. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92702-2 · Cited by 180
Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors
Ogata, E., Ritz, E., Odoni, G., Amann, K., & Orth, S. R. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000056188.23717.e5 · Cited by 149
Self-citationNagano, N., Miyata, S., Abe, M., Kobayashi, N., Wakita, S., Yamashita, T., & Wada, M. (2006) · Kidney International · doi:10.1038/sj.ki.5000020 · Cited by 143
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats
Panichi, V., MIGLIORI, M., Taccola, D., Filippi, C., Nisco, L. D., Giovannini, L., Palla, R., Tetta, C., & Camussi, G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00775.x · Cited by 114
Boes, E., Fliser, D., Ritz, E., König, P., Lhotta, K., Mann, J. F. E., Muller, G. A., Neyer, U., Riegel, W., Riegler, P., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070733 · Cited by 87
Self-citationNarang, R., Ridout, D. A., Nonis, C., et al. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(97)02971-9 · Cited by 82
With or without the kidney: the role of FGF23 in CKD
Fukagawa, M., & Kazama, J. J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh827 · Cited by 63
Role of calcium-phosphorous disorders in the progression of renal failure
Ritz, E., Gross, M., & Dikow, R. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09912.x · Cited by 32
Self-citationCalcium, Calcium Regulatory Hormones, and Calcimimetics
Schmitt, C. P., Odenwald, T., & Ritz, E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121338 · Cited by 27
Self-citation
Cited by
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287
(2017) · Kidney International Supplements · doi:10.1016/j.kisu.2017.04.001 · Cited by 1,956
Isakova, T., on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Wahl, P., Vargas, G. S., Gutiérrez, O. M., Scialla, J., Xie, H., Appleby, D., Nessel, L., Bellovich, K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.47 · Cited by 1,266
Isakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Metadata
- Authors
- Fliser, D., Kollerits, B., Neyer, U., Ankerst, D. P., Lhotta, K., Lingenhel, A., Ritz, E., & Kronenberg, F.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-09
- Volume
- 18
- Issue
- 9
- Pages
- 2600-2608
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2095948376
- Cited by
- 699
- References
- 31
- FWCI
- 20.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.